Tuberculosis Therapy
Whole blood bactericidal activity useful as treatment efficacy marker
Published in TB and Outbreaks Week, February 11th, 2003
"The timely evaluation of new drugs that can be used to shorten tuberculosis (TB) treatment will require surrogate markers for relapse," explained Robert S. Wallis and colleagues at the University of Medicine and Dentistry of New Jersey in Newark, Case Western Reserve University in Cleveland, the University of Arkansas for Medical Sciences in Little Rock, and Universidade Federal do Espiritu Santo in Espiritu Santo, Brazil.
Whole blood bactericidal activity (WBA) is highly useful as a relapse marker, Wallis and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Cerebral Malaria
Platelet accumulation in brain linked to pathogenesis - Infectious Disease
Cytomegalovirus tegument protein pp65 useful for specific immunity research - Stem Cell Transplantation
Granulocyte transfusion effective against post-transplant meningoencephalitis - Stem Cell Transplantation
Myeloid progenitors protect against invasive aspergillosis, Pseudomonas infections - Bacterial Meningitis
Pathogenesis and pathophysiology is due to inflammatory response - Bacteriology
New drug lead fights bacteria that disrupt quorum sensing and biofilms - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
